David J. Maki J.D. Net Worth

The estimated Net Worth of David Maki is at least $409 Thousand dollars as of 15 June 2015. Mr Maki owns over 72,750 units of Pulmatrix Inc stock worth over $409,114 and over the last 9 years he sold PULM stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr D PULM stock SEC Form 4 insiders trading

Mr has made over 1 trades of the Pulmatrix Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 72,750 units of PULM stock worth $500,520 on 15 June 2015.

The largest trade he's ever made was buying 72,750 units of Pulmatrix Inc stock on 15 June 2015 worth over $500,520. On average, Mr trades about 72,750 units every 0 days since 2015. As of 15 June 2015 he still owns at least 218,194 units of Pulmatrix Inc stock.

You can see the complete history of Mr Maki stock trades at the bottom of the page.

Mr. David J. Maki J.D. biography

David J. Maki J.D. is the Advisor at Pulmatrix Inc.

How old is Mr D?

Mr D is 63, he's been the Advisor of Pulmatrix Inc since . There are 5 older and 10 younger executives at Pulmatrix Inc. The oldest executive at Pulmatrix Inc is Dr. Robert S. Langer Jr., Ph.D., Sc.D., SCD, 72, who is the Founder & Member of Scientific Advisory Board.

What's Mr D's mailing address?

David's mailing address filed with the SEC is C/O PULMATRIX, INC, 990 HAYDEN AVE, LEXINGTON, MA, 02421.

Insiders trading at Pulmatrix Inc

Over the last 9 years, insiders at Pulmatrix Inc have traded over $4,537,500 worth of Pulmatrix Inc stock and bought 290,998 units worth $2,002,066 . The most active insiders traders include Steven Gillis, Terrance Mcguire, and Innovative Sciences, Inc. O.... On average, Pulmatrix Inc executives and independent directors trade stock every 92 days with the average trade being worth of $521,728. The most recent stock trade was executed by David L. Hava on 20 March 2017, trading 2,263 units of PULM stock currently worth $5,001.

What does Pulmatrix Inc do?

pulmatrix is a clinical stage biotechnology company with an inhaled dry powder platform advancing a new generation of inhaled therapeutics. the platform, called isperse (inhaled small particles easily respirable and emitted), represents a new paradigm in inhaled drug delivery based on unique properties: dense, high drug load engineered particles with highly efficient dispersibility and delivery to the airways. the isperse powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance.

Complete history of Mr Maki stock trades at Pulmatrix Inc

Pulmatrix Inc executives and stock owners

Pulmatrix Inc executives and other stock owners filed with the SEC include:

• Teofilo Raad,
  President, Chief Executive Officer, Director
• Teofilo David Raad MBA,
  Pres, CEO & Director
• Teofilo David Raad,
  Pres, CEO & Director
• Michelle S. Siegert,
  VP of Fin. and Principal Financial & Accounting Officer
• Michelle Siegert,
  Vice President - Finance
• Michael Higgins,
  Independent Chairman of the Board
• Timothy McCarthy,
  Investor Relations
• Amit Munshi,
  Independent Director
• Mark Iwicki,
  Independent Director
• Rick Batycky,
  Independent Director
• Christopher Cabell,
  Director
• Todd Bazemore,
  Director
• Dr. Margaret M. Wasilewski M.D.,
  Chief Medical Officer
• Peter Ludlum CMA, MBA,
  Interim CFO and Principal Accounting & Financial Officer
• Dr. Robert S. Langer Jr., Ph.D., Sc.D., SCD,
  Founder & Member of Scientific Advisory Board
• David J. Maki J.D.,
  Advisor
• Dr. Alexander M. Klibanov Ph.D.,
  Founder
• Prof. David A. Edwards,
  Founder & Member of Scientific Advisory Board
• Dr. Robert S. Langer Jr.,
  Founder & Member of Scientific Advisory Board
• Steven Arch Venture Fund Vi...,
  
• David L. Hava,
  Chief Scientific Officer
• Matthew L Sherman,
  Director
• William E. Duke,
  Chief Financial Officer
• Robert W. Clarke,
  Chief Executive Officer
• Steven Gillis,
  Director
• Kurt Graves,
  Director
• Terrance Mcguire,
  Director
• Scott M Rocklage,
  Director
• Richard P. Batycky,
  Director
• Venture Fund Vii, L.P.Arch ...,
  
• James M. Roach,
  Chief Medical Officer
• Terrance Flint Jonathan A P...,
  
• Innovative Sciences, Inc. O...,
  10% owner
• David Maki,
  Director
• Anand Varadan,
  Director
• Margaret Wasilewski,
  Chief Medical Officer